NR was first discovered in 2004 and became available as a dietary supplement starting in 2013
Landscapes Health & Medical Sciences (AREA) Chemical & Material Sciences (AREA) Organic Chemistry (AREA) Life Sciences & Earth Sciences (AREA) General Health & Medical Sciences (AREA) Medicinal Chemistry (AREA) Bioinformatics & Cheminformatics (AREA) Engineering & Computer Science (AREA) Veterinary Medicine (AREA) Animal Behavior & Ethology (AREA) Public Health (AREA) Pharmacology & Pharmacy (AREA) Chemical Kinetics & Catalysis (AREA) General Chemical & Material Sciences (AREA) Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA) Neurology (AREA) Biomedical Technology (AREA) Neurosurgery (AREA) Proteomics, Peptides & Aminoacids (AREA) Biochemistry (AREA) Molecular Biology (AREA) Genetics & Genomics (AREA) Biophysics (AREA) Crystallography & Structural Chemistry (AREA) Orthopedic Medicine & Surgery (AREA) Psychiatry (AREA) Psychology (AREA) Ophthalmology & Optometry (AREA) Physical Education & Sports Medicine (AREA) Hospice & Palliative Care (AREA) Dermatology (AREA) Epidemiology (AREA) Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA) Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA) Peptides Or Proteins (AREA) Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA) Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA) Abstract The present technology relates to compounds, kits, compositions, and methods useful for the treatment of numerous pathologies including dementia, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and other neurodegenerative diseases, spinal cord injury, traumatic brain injury, diabetes and metabolic syndrome, defective wound healing, and/or sensorineural hearing and vision loss
This, in turn, boosts metabolic rate and activates a gene known as sirtuin-1 (SIRT1), also referred to as the "longevity gene." SIRT1 is involved in reducing the risk of various conditions such as diabetes, obesity, metabolic syndrome, atherosclerosis, cardiovascular disease, kidney disease, liver disease, neurodegeneration, and cancer.
91,201204 Since then, AMPK stimulation has been widely suggested as a therapeutic target for TJ-associated GI diseases, for example, IBD 205 and colorectal cancer
References American Society of Clinical Oncology (ASCO)
